A new trading day began on Friday, with Merck & Co Inc (NYSE: MRK) stock price down -0.92% from the previous day of trading, before settling in for the closing price of $109.18. MRK’s price has ranged from $73.31 to $112.90 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 12.04% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 16.91%. With a float of $2.48 billion, this company’s outstanding shares have now reached $2.49 billion.
Merck & Co Inc (MRK) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Merck & Co Inc is 0.10%, while institutional ownership is 79.41%. The most recent insider transaction that took place on Nov 10 ’25, was worth 616,395. In this transaction Chief Comm. & Public Afrs Ofcr of this company sold 7,085 shares at a rate of $87.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 10 ’25, when Company’s Officer proposed sale 7,085 for $87.00, making the entire transaction worth $616,395.
Merck & Co Inc (MRK) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 1.72 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.93% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Here are Merck & Co Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.20. Likewise, its price to free cash flow for the trailing twelve months is 20.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.56, a number that is poised to hit 2.02 in the next quarter and is forecasted to reach 5.38 in one year’s time.
